Skip Navigation


Rheumatology Advance Access originally published online on August 3, 2004
Rheumatology 2004 43(10):1219-1223; doi:10.1093/rheumatology/keh321
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/10/1219    most recent
keh321v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rall, L. C.
Right arrow Articles by Roubenoff, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rall, L. C.
Right arrow Articles by Roubenoff, R.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 10 © British Society for Rheumatology 2004; all rights reserved

Review

Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions

L. C. Rall and R. Roubenoff1,2

Marshfield Clinic Research Foundation, Epidemiology Research Center, Marshfield, WI, 1 Millennium Pharmaceuticals, Inc., Cambridge and 2 Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA

Correspondence to: L. C. Rall, Epidemiology Research Center, ML-2, Marshfield Clinic Research Foundation, 1000 N. Oak Avenue, Marshfield, WI 54449, USA. E-mail: rall.laura{at}mcrf.mfldclin.edu

We have previously identified the phrase ‘rheumatoid cachexia’ to describe the loss of body cell mass (BCM) that may occur among patients with rheumatoid arthritis (RA). Specifically, rheumatoid cachexia is characterized by altered energy and protein metabolism (reduced total energy expenditure, increased resting energy expenditure and increased whole-body protein catabolism) and increased inflammatory cytokine production (interleukin-1ß and tumour necrosis factor-{alpha}). Patients with rheumatoid cachexia consistently have a diet that appears adequate in protein and calories (based on US Dietary Reference Intakes), but with reduced physical activity. These phenomena are similar to some of the metabolic abnormalities that occur with normal ageing, but the aetiology appears to be different in RA. This review will focus on describing the metabolic abnormalities observed in rheumatoid cachexia, identifying potential mechanisms for loss of BCM and discussing strategies for intervention.

KEY WORDS: Rheumatoid arthritis, Cachexia, Protein metabolism, Muscle, Body cell mass, Interleukin-1ß, Tumour necrosis factor-{alpha}, Exercise


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J EndocrinolHome page
R Hardy and M S Cooper
Bone loss in inflammatory disorders
J. Endocrinol., June 1, 2009; 201(3): 309 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. D. Summers, C. M. Deighton, M. J. Rennie, and A. H. Booth
Rheumatoid cachexia: a clinical perspective
Rheumatology, August 1, 2008; 47(8): 1124 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. S. Metsios, A. Stavropoulos-Kalinoglou, V. F. Panoulas, Y. Koutedakis, A. M. Nevill, K. M. J. Douglas, M. Kita, and G. D. Kitas
New resting energy expenditure prediction equations for patients with rheumatoid arthritis
Rheumatology, April 1, 2008; 47(4): 500 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. S. Metsios, A. Stavropoulos-Kalinoglou, J. J. C. S. Veldhuijzen van Zanten, G. J. Treharne, V. F. Panoulas, K. M. J. Douglas, Y. Koutedakis, and G. D. Kitas
Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review
Rheumatology, March 1, 2008; 47(3): 239 - 248.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. S. Metsios, A. Stavropoulos-Kalinoglou, K. M. J. Douglas, Y. Koutedakis, A. M. Nevill, V. F. Panoulas, M. Kita, and G. D. Kitas
Blockade of tumour necrosis factor-{alpha} in rheumatoid arthritis: effects on components of rheumatoid cachexia
Rheumatology, December 1, 2007; 46(12): 1824 - 1827.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
A. Stavropoulos-Kalinoglou, G. S Metsios, Y. Koutedakis, A. M Nevill, K. M Douglas, A. Jamurtas, J. J C S V. van Zanten, M. Labib, and G. D Kitas
Redefining overweight and obesity in rheumatoid arthritis patients
Ann Rheum Dis, October 1, 2007; 66(10): 1316 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. Marcora, F. Casanova, E. Williams, J. Jones, R. Elamanchi, and A. Lemmey
Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis
Rheumatology, November 1, 2006; 45(11): 1385 - 1388.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M Otero, R Lago, R Gomez, F Lago, C Dieguez, J J Gomez-Reino, and O Gualillo
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis
Ann Rheum Dis, September 1, 2006; 65(9): 1198 - 1201.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.